CVE-2026-87356 Oracle Applications Platform Engineering
| Affected software | Oracle Applications Platform Engineering |
|---|---|
| Affected versions | 12.2.3-12.2.15 |
| Severity | 7.8 High CVSS 3.1 |
| Fixed in | Oracle Critical Patch Update October 2026 |
| Weakness | Information exposure (CWE-200) |
| Published | 20 Oct 2026 |
| Updated | 31 Oct 2026 |
Published 24 days ago. NVD often adds the list of affected products days or weeks after a CVE is published, and the other sources we check lag too. The scope and status here may change.
Description
Vulnerability in the Applications Platform Engineering product of Oracle E-Business Suite (component: Valid Session). Supported versions that are affected are 12.2.3-12.2.15. Easily exploitable vulnerability allows low privileged attacker with logon to the infrastructure where Applications Platform Engineering executes to compromise Applications Platform Engineering. Successful attacks of this vulnerability can result in takeover of Applications Platform Engineering. CVSS 3.1 Base Score 7.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).
Exploitation status
No public exploit
No exploit has been reported in the sources we check.
Exploitation status
- CISA KEV not listed
- VulnCheck KEV not listed
- CISA Vulnrichment exploitation: none
- Indexed PoC none indexed
- EPSS 0.15% chance in 30 days
Waratek protection
Within Waratek scope. In the sources we check, nobody has published exploit code for this CVE or reported it being exploited.
This is a proprietary Oracle product. Oracle's security advisory is the source of public detail for this CVE.
- Protection none
- Action not pursued
- Review automated Upstream data
- Record active
| Decided by | Nothing to build a rule from yet: no published exploit, no CISA record of exploitation and no source-level change to read |
|---|---|
| Finding | This CVE affects a known product, but nothing published names a fix and nothing published shows an exploit. That is a statement about the evidence, not about the defect — it does not mean the vulnerability is unimportant or unreachable, only that neither of the two things VRT can act on exists. |
Affected software and releases
Oracle advisories
| Advisory | Type | Quarter | Products Oracle names in its risk matrix |
|---|---|---|---|
| Oracle Critical Patch Update October 2026 ↗ | CPU | 2026-Q4 | Oracle E-Business Suite / Valid Session (12.2.3-12.2.15) |
Oracle components and versions
| Family | Component | Versions, as Oracle lists them | Read as |
|---|---|---|---|
| Oracle E-Business Suite | Valid Session | 12.2.3-12.2.15 |
References
| URL | Tags |
|---|---|
| https://www.oracle.com/security-alerts/cpuoct2026.html |
Timeline
Timeline
| Published | 2026-10-20 | By the CVE Program. |
|---|---|---|
| NVD record modified | 2026-10-31 | NVD's own last-modified date for this record. |